PreOmics is as a spin-off from the proteomics research group of pioneer Matthias Mann at the Max-Planck Institute of Biochemistry founded by Dr. Nils A. Kulak and Dr. Garwin Pichler. These two entrepreneurs have been researching and developing their idea with funding of the M4-award since 2014. PreOmics develops and provides innovative tools for customers around the world for mass spectrometry (MS)-based proteomics using cutting-edge technologies to support researchers in their protein analysis needs. We at PreOmics provide the best possible solutions, the highest quality standards to enable a user-friendly and intuitive use of MS-based proteomics.